Onyx Enrolls FOCUS Patients – Analyst Blog

By | October 22, 2012
0 Comment

Onyx Pharmaceuticals, Inc. ( ONXX ) recently announced that it has finished enrolling patients for the phase III FOCUS (Car F ilz O mib for Advan C ed Refractory M U ltiple

Read More:
Onyx Enrolls FOCUS Patients – Analyst Blog

Related posts:

  1. Catalyst-Filled 2013 for Onyx – Analyst Blog
  2. Onyx Pharmaceuticals (ONXX) – Bull of the Day
  3. Pre-Market Primer: Amgen, Inc. to Acquire Onyx Pharmaceuticals; Durable Goods Order Plunge
  4. Alnylam-ISIS Venture Prices IPO – Analyst Blog